Trilogy Capital Inc. has recently filed its 13F-HR report with the SEC, detailing its investment holdings as of September 30, 2026. This filing is significant as it provides insights into the company's investment strategy and asset allocation within the financial services sector.
The report, filed on October 20, 2026, shows that Trilogy Capital has made substantial investments in various well-known companies. Notable holdings include 3M Co., Abbott Laboratories, and Apple Inc., among others. The total value of the reported holdings amounts to approximately $2.6 billion, indicating a diversified portfolio aimed at maximizing returns while managing risk.
Trilogy Capital Inc. is incorporated in California and operates primarily within the financial services industry. The company has been actively managing its investments, as evidenced by its recent filings, including a previous 13F-HR submission on July 6, 2026. This consistent reporting showcases the company's commitment to transparency and regulatory compliance.
The latest filing reveals a total of 427 entries, with a reported total value of $2,605,284,699. This comprehensive overview of holdings reflects Trilogy's strategic approach to investment management. The filing also indicates that the company exercises sole investment discretion over its reported holdings, further emphasizing its active management strategy.
Among the companies in which Trilogy has invested, 3M Co. stands out with a reported value of $240,883, while Abbott Laboratories holds a value of $642,000. Apple Inc. is another significant investment, valued at approximately $13,401,404. These investments highlight Trilogy's focus on established firms with strong market positions.
The impact of this filing extends beyond Trilogy Capital itself. As the financial services industry continues to evolve, the investment strategies of firms like Trilogy can influence market trends and investor behavior. The diversification of Trilogy's portfolio may serve as a model for other investment firms seeking to navigate the complexities of the current market environment.
Looking ahead, it remains to be seen how Trilogy Capital will adjust its investment strategy in response to market dynamics. The filing does not specify any upcoming votes or changes in management, leaving investors and analysts to speculate on future developments.
In summary, Trilogy Capital Inc.'s latest 13F-HR filing provides valuable insights into its investment holdings and strategies. With significant investments in major companies, Trilogy's approach reflects a commitment to active management and diversification within the financial services sector.